Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B.
Alessandro LoglioMassimo IavaroneG GrossiM ViganòMaria Grazia RumiF FacchettiGiovanna LunghiA SangiovanniM ColomboPietro LamperticoPublished in: Alimentary pharmacology & therapeutics (2018)
HCCs developing in patients under long-term NUC treatment were single, small tumours, amenable to curative therapies able to confer excellent 5-year survival rates.